[
  {
    "ts": null,
    "headline": "Edwards Lifesciences (NYSE:EW) Presents Promising AS Treatment Data At ACC Session",
    "summary": "Edwards Lifesciences (NYSE:EW) recently announced significant findings at the ACC Annual Scientific Session, showcasing crucial research in the treatment of structural heart disease. This development, alongside data indicating the increased effectiveness of electronic notifications in treating severe aortic stenosis, comes amid broader market volatility. The past week saw a 1.58% rise in Edwards Lifesciences' stock, contrasting with a 3.4% drop in the overall market as concerns about tariffs...",
    "url": "https://finnhub.io/api/news?id=65199fd209257ce000590400df48de8d8faec2af83d8e07591d91ad387a7a59d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743529788,
      "headline": "Edwards Lifesciences (NYSE:EW) Presents Promising AS Treatment Data At ACC Session",
      "id": 133655324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences (NYSE:EW) recently announced significant findings at the ACC Annual Scientific Session, showcasing crucial research in the treatment of structural heart disease. This development, alongside data indicating the increased effectiveness of electronic notifications in treating severe aortic stenosis, comes amid broader market volatility. The past week saw a 1.58% rise in Edwards Lifesciences' stock, contrasting with a 3.4% drop in the overall market as concerns about tariffs...",
      "url": "https://finnhub.io/api/news?id=65199fd209257ce000590400df48de8d8faec2af83d8e07591d91ad387a7a59d"
    }
  },
  {
    "ts": null,
    "headline": "Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities",
    "summary": "Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in crucial areas of positive structural transformation within the economy. The fund returned 8.8% (net) in the fourth […]",
    "url": "https://finnhub.io/api/news?id=882f163e1d3c50931f57f91d0ef2501fc208e10c8065c214bf94526b5a900e3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743513501,
      "headline": "Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities",
      "id": 133645803,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in crucial areas of positive structural transformation within the economy. The fund returned 8.8% (net) in the fourth […]",
      "url": "https://finnhub.io/api/news?id=882f163e1d3c50931f57f91d0ef2501fc208e10c8065c214bf94526b5a900e3e"
    }
  }
]